title: FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
authors.forename: J S
authors.initials: JS
authors.lastname: James
mesh_terms: D019587:Dietary Supplements; D004348:Drug Labeling; D006801:Humans; D007880:Legislation, Drug; D011639:Public Opinion; D014486:United States Food and Drug Administration